Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 10/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.79 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2623193 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL8850330 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL12200707 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL8850378 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL21641757 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL8851036 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL8851479 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL10071416 | 1.00 | TSHR (0.79) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL153585 | 0.98 | TSHR (0.75) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL439108 | 0.94 | TSHR (0.68) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250135059-A1 | COMPOSITIONS COMPRISING FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY | 2025-05-01 | — | — | US | disclosed |
| WO-2025047819-A1 | AQUEOUS DISPERSION OF NITRILE RUBBER PARTICLES | 日本ゼオン株式会社 | 2025-03-06 | — | — | WO | disclosed |
| US-20240254423-A1 | CELL CAPTURE DEVICE, CELL CAPTURE APPARATUS, AND CELL CAPTURE METHOD | PHC HOLDINGS CORPORATION (JP) | 2024-08-01 | — | — | US | disclosed |
| EP-4379036-A1 | CELL CAPTURE DEVICE, CENTRIFUGAL CONTAINER, CELL CAPTURE APPARATUS, AND CELL CAPTURE METHOD | PHC Holdings Corporation (JP) | 2024-06-05 | — | — | EP | disclosed |
| CN-111801360-B | Method for recovering unreacted alpha, beta-ethylenically unsaturated nitrile monomer contained in latex of carboxyl group-containing nitrile rubber | 日本瑞翁株式会社 | 2024-02-09 | — | — | CN | disclosed |
| US-11737345-B2 | Organic electronic material, ink composition containing same, and organic thin film, organic electronic element, organic electroluminescent element, lighting device, and display device formed therewith | RESONAC CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| US-11737345-B2 | Organic electronic material, ink composition containing same, and organic thin film, organic electronic element, organic electroluminescent element, lighting device, and display device formed therewith | RESONAC CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| US-20230212136-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT | FUJIFILM CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20230212136-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT | FUJIFILM CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| EP-3176190-B1 | NITRILE-GROUP-CONTAINING COPOLYMER RUBBER, CROSSLINKABLE RUBBER COMPOSITION, AND CROSSLINKED RUBBER | ZEON CORP (JP) | 2023-03-29 | — | — | EP | disclosed |
| EP-1266910-A1 | PROCESS FOR THE PRODUCTION OF LIVING (CO)POLYMERS AND USE OF THE (CO)POLYMERS | Mitsui Chemicals, Inc. (JP) | 2002-12-18 | — | — | EP | disclosed |
| EP-1044989-A1 | Method for preparing polymer | Mitsui Chemicals, Inc. (JP) | 2000-10-18 | — | — | EP | disclosed |
| US-5292965-A | Monomethoxy propoxylated glycerol | DIAMOND SHAMROCK CHEMICALS COMPANY | 1994-03-08 | — | — | US | disclosed |
| US-5243085-A | Starting materials for improved radiation hardenable diluents | DIAMOND SHAMROCK CHEMICAL CO. (US) | 1993-09-07 | — | — | US | disclosed |
| US-5159119-A | Monomethyl ether of trans 1,4-cyclohexanedimethylol | DIAMOND SHAMROCK CHEMICALS COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
| EP-0222059-B1 | IMPROVED RADIATION-HARDENABLE DILUENTS | HENKEL CORPORATION (a Delaware corp.) (US) | 1992-07-08 | — | — | EP | disclosed |
| US-5110889-A | Lower alkyl ether acrylates of polyols; coatings | DIAMOND SHAMROCK CHEMICAL CO. (US) | 1992-05-05 | — | — | US | disclosed |
| US-5053554-A | Monomethyl ether of an ethoxylated or propoxylated(2 average) neopentyl glycol; nonvolatile coating formulation; fact cure; low viscosity; shrinkage inhibition; rheology | DIAMOND SHAMROCK CHEMICAL COMPANY | 1991-10-01 | — | — | US | disclosed |
| US-4876384-A | ALKYL ETHER ACRYLATES AND METHACRYLATES OF ALKOXYLATED AND NONALKOXYLATED POLYOLS; LOW VISCOSITY; SHRINKAGE INHIBITION | DIAMOND SHAMROCK CHEMICALS CO. (US) | 1989-10-24 | — | — | US | disclosed |
| EP-0222059-A2 | Improved radiation-hardenable diluents | HENKEL CORPORATION (a Delaware corp.) (US) | 1987-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212136-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT | TERB1, RER1, LARP1 | TSHR 3138/4885ALDH1A1 228/4885CYP3A4 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.